These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11375228)

  • 41. Interventions for bronchiectasis: an overview of Cochrane systematic reviews.
    Welsh EJ; Evans DJ; Fowler SJ; Spencer S
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010337. PubMed ID: 26171905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucolytics for bronchiectasis.
    Wilkinson M; Sugumar K; Milan SJ; Hart A; Crockett A; Crossingham I
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD001289. PubMed ID: 24789119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.
    Miravitlles M; Mayordomo C; Artés M; Sánchez-Agudo L; Nicolau F; Segú JL
    Respir Med; 1999 Mar; 93(3):173-9. PubMed ID: 10464874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review.
    Steurer-Stey C; Bachmann LM; Steurer J; Tramèr MR
    Chest; 2004 Nov; 126(5):1645-55. PubMed ID: 15539739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of mucolytics in COPD: A Delphi consensus study.
    Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
    Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
    Wood-Baker RR; Gibson PG; Hannay M; Walters EH; Walters JA
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001288. PubMed ID: 15674875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aclidinium bromide for stable chronic obstructive pulmonary disease.
    Ni H; Soe Z; Moe S
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010509. PubMed ID: 25234126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
    Cazzola M; Floriani I; Page CP
    Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009285. PubMed ID: 25046211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.
    Papi A; Zheng J; Criner GJ; Fabbri LM; Calverley PMA
    Respir Med; 2019 Feb; 147():37-43. PubMed ID: 30704697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statins versus placebo for people with chronic obstructive pulmonary disease.
    Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.
    Threapleton CJ; Janjua S; Fortescue R; Baker EH
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013024. PubMed ID: 31125127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erdosteine: its relevance in COPD treatment.
    Moretti M
    Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):333-43. PubMed ID: 19331595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.